Skip to content
MarketScale
‹ Back to IndustriesSciences

Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Novaspace forecasts more than 6,500 Earth observation satellites launching by 2035. It also projects $155.9 billion in manufacturing revenue, based on a SpaceNews-posted release dated Aug. 21, 2026. As defense-led demand shifts toward revisit rate and persistence, payload integration and fleet interoperability become the hard parts.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By MarketScale Newsroom · NovaspaceSpacenewsEarth ObservationEo Satellites
Share
Learn this in 60 seconds

Key facts, context, and what it means, in one minute.

:60
0:001:00
Novaspace sees 6,500+ Earth observation satellites by 2035, and value shifts to payload integration

Key takeaways

01

$155.9 billion is tied specifically to satellite manufacturing, not launch or ground, which should reshape how teams size supplier commitments and make-buy decisions.

02

Novaspace’s “skyscraper model” framing implies procurement power is shifting to payload integration, test capacity, and software-defined operations, even as the bus becomes more standardized.

Get featured

Want to get featured in MarketScale Sciences?

Create a free MarketScale workspace and get your company's expertise featured across our Sciences coverage. No credit card, no demo required.

Request an invite

More than 6,500 Earth observation satellites are expected to launch by 2035, and Novaspace puts the associated manufacturing revenue at $155.9 billion. That forecast, published Aug. 21, 2026 in a SpaceNews-posted Novaspace release, is a reminder that the space industrial base is no longer being asked to build a handful of exquisite spacecraft. It’s being asked to build fleets, with defense-grade tasking expectations.

For operators inside satellite primes, payload suppliers, and program offices, the same Novaspace release highlights a shift that matters beyond the headline totals. According to SpaceNews, Novaspace says performance is being measured more by revisit rates, persistence and wide-area coverage than by resolution alone. That change is pushing operators toward bigger constellations and a wider mix of sensor designs.

The number that will show up in supplier negotiations: $155.9 billion in manufacturing

Novaspace is explicit about what its $155.9 billion represents: manufacturing revenues tied to Earth observation satellites through 2035, driven by governments expanding sovereign intelligence, surveillance, and reconnaissance capabilities, according to SpaceNews. That scope matters for procurement teams who keep seeing “space market” numbers that quietly bundle launch, ground infrastructure, and downstream services into a single pie chart.

Treat this forecast as a budgeting reality check. If manufacturing is the cited revenue pool, then capacity planning conversations should land on long-lead components, test throughput, and qualified suppliers, not just launch cadence or downlink capacity.

Multi-sensor constellations raise integration work even as buses standardize

According to SpaceNews, Novaspace says the change is speeding up use of multi-sensor constellations that pair synthetic aperture radar (SAR), optical and radio frequency (RF) payloads. Novaspace says that bringing together complementary intelligence sources can deliver Earth observation that is both more resilient and more comprehensive, while still satisfying increasingly demanding defense requirements.

The SpaceNews-posted release also outlines a “skyscraper model.” According to Novaspace, as satellite buses become more standardized, value shifts to integrating advanced payloads along with multiple intelligence layers.

Interoperability and fleet management become part of the spec

As constellations scale, Novaspace says demand is rising for interoperability, federation, and fleet management, according to SpaceNews. Those words can read like strategy, but they turn into line items fast: cross-mission tasking, common data standards, shared command-and-control workflows, and operational tooling that can handle mixed vendors and mixed sensors without bespoke integration every time.

As EO constellations increase in size and complexity, Novaspace says the need is rising for interoperability, federation and fleet management, according to SpaceNews. Novaspace says those developments are bringing commercial and defense markets closer together and making sovereign Earth observation capabilities a central engine of market growth through 2035.

A separate Novaspace forecast points to rate production stress

The EO forecast lands inside a broader manufacturing ramp. CompositesWorld, in an Oct. 10, 2025 item edited by Ginger Gardiner, reported Novaspace’s projection that 43,000 satellites would be launched in 2025, 2034, averaging 12 satellites per day, and tied the growth to mega-constellations, defense demand, and rapid innovation.

Even though that is a different Novaspace report and timeframe, it provides a production-rate reference point for suppliers watching EO specifically. CompositesWorld reports that Novaspace’s annual forecast calls for record growth in satellites to be built and launched, averaging 12 satellites per day, and notes that this growth will drive increased use of composites in launch vehicle and satellite structures. If the industry is organized around “satellites per day,” then materials and structures suppliers have to plan for qualification pathways that look more like aerospace series production than one-off space builds.

Questions to bring into 2027 EO constellation sourcing and integration

  • For payload and subsystem buyers: how will vendors commit to interface stability (mechanical, electrical, software) across SAR, optical, and RF payload mixes over multiple lots, given Novaspace’s multi-sensor direction (SpaceNews)?
  • For manufacturing ops leaders: what is the limiting resource in the schedule, payload availability, integration labor, or environmental test throughput, if bus standardization rises as Novaspace’s “skyscraper model” suggests (SpaceNews)?
  • For program and ground-segment teams: what concrete interoperability requirements belong in the RFP now (tasking APIs, data formats, federation rules), since Novaspace flags interoperability and federation demand as constellations scale (SpaceNews)?
  • For materials and structures suppliers: what production-rate assumptions are realistic for composite parts and panel fabrication if industry forecasts are being expressed in “satellites per day,” as CompositesWorld summarized from Novaspace’s 2025-2034 outlook?

Featured companies

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

MarketScale Newsroom
MarketScale NewsroomEditorial Team, MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

Follow Sciences Insights

Get new expert content in your inbox.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Sciences Insights

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS ran an AI controller on a distillation column for 35 days and cut steam use 40%

ENEOS Materials and Yokogawa ran an autonomous AI controller on a butadiene distillation column for 35 days and cut steam use 40%. It’s a real operations proof point. It also puts integration and governance gaps front and center.

  • 01A 35-day closed-loop run is a stronger autonomy proof point than a demo, it forces plants to prove handover, fallback, and KPIs over real feed and operating swings.
  • 02Steam reduction claims are compelling, but procurement and ops teams should pin vendors to baselines, operating envelopes, and how off-spec avoidance is measured.
  • 03Agentic AI is showing up as “work management” and “shift checklist” agents before it replaces control engineers, which shifts requirements toward clean, permissioned data access.

Sep 13, 2026

Samsung Biologics signs $262M manufacturing deal through 2033, pushing longer CDMO bookings

Samsung Biologics signs $262M manufacturing deal through 2033, pushing longer CDMO bookings

Samsung Biologics disclosed a $262 million biologics manufacturing contract running through 2033. The work will be produced at Songdo, South Korea. The deal lifts Samsung Biologics’ cumulative contract value above $21.9 billion, per BioPharm International.

  • 01Duration is the headline: Samsung Biologics’ new $262 million contract with an unnamed European pharma company runs through Dec. 31, 2033, a long-dated commitment for the Songdo site (per BioPharm International).
  • 02CDMO selection is drifting from “price per batch” to “operating model”: Samsung Biologics executives have framed CDMOs as extensions of sponsor operations, which raises expectations for transparency, change control, and schedule flexibility (per BioPharm International).

Sep 13, 2026

Robotic Systems Emerge for Cell and Gene Therapy Manufacturing

Robotic Systems Emerge for Cell and Gene Therapy Manufacturing

A September 2024 Cytotherapy paper describes a robotic cluster designed to automate manual steps in cell therapy manufacturing. Additional reviews published in 2019 and 2026, along with commentary from Genetic Engineering and Biotechnology News, discuss automation and AI as tools being explored for the cell and gene therapy manufacturing sector.

  • 01A robotic cluster combining a robotic arm with customized modules can handle standard cell therapy equipment (incubators, bioreactors, reagent bags) without requiring entirely new manufacturing platforms.
  • 02The system produced human CD8+ T cells with cell yields, viability and identity comparable to manual cultures while maintaining sterility, according to the Cytotherapy paper.
  • 03Manufacturing automation and AI are cited in industry analysis as potential solutions to skilled labor shortages and production scaling challenges, particularly for allogeneic therapies manufactured at larger scale.

Sep 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

MarketScale Newsroom
MarketScale Newsroom

Editorial Team

MarketScale

The MarketScale Newsroom reports on the companies, technologies, and trends shaping 16 B2B industries. It turns primary sources and expert commentary into clear, useful coverage for the people doing the work.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512